Biotech Support Group LLC

MONMOUTH JUNCTION, NJ -- Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid clearance sample preparation technology for the proteomic analysis of bile fluid.

Biotech Support Group presented a poster describing a biomarker panel of cancer dysregulation derived from serum proteomic profiles, at the New Jersey Cancer Retreat held on May 25, 2017 in New Brunswick, NJ.

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid clearance technology for cell culture lysates. The citation is: Ahmed, Syed Mukhtar, and Ian G. Macara.

Biotech Support Group reports on a new research report which highlights the simplicity and efficiency of their proteomic sample preparation technology as an initial enrichment step to the Array Bridge (St. Louis, MO) Protein Elution Plate (PEP).

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid clearance sample preparation technology for bile fluid. The citation is: Vesterhus, Mette, et al.

Biotech Support Group reports on a recent patent using AlbuSorb™ as part of the description of the invention. The citation is: Berggren, Per-olof, and Lisa Juntti-berggren. "Methods for treating and/or limiting development of diabetes." U.S. Patent No.

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for improving the signal from whole blood protein immunoblot analysis. The citation is: Lahut, Suna, et al.

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching the red cell sub-proteome, from human red blood cells.

Biotech Support Group reports on a recent patent reporting the simplicity and efficiency of their hemoglobin depletion technology for removing interferences from a Bilirubin assay in an example describing complement-mediated diseases.

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for improving the signal from an exosome assay obtained from hemolyzed mouse sera.